Positive Efficacy and Safety Outcomes Results From Second-Line Liso-Cel in LBCL.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 47
- Publication type:
- Article
Works matching IS 08909091 AND DT 2025 AND VI 39 AND IP 1
Results: 13
1
2
ESAs Yield Response in VEXAS Syndrome With or Without MDS.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 47
- Publication type:
- Article
3
Overall MRD Negativity Rates Improved With Cilta-Cel vs SOC in MM.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 46
- Publication type:
- Article
4
Subcutaneous Epcoritamab Elicits Deep Responses in Heavily Pretreated CLL.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 46
- Publication type:
- Article
5
Neoadjuvant HER3-DXd Maintains Response Rates With Fewer TRAEs in Breast Cancer.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 45
- Publication type:
- Article
6
Surgical Intervention Improves Efficacy in Young Patients With Breast Cancer.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 45
- Publication type:
- Article
7
Elacestrant/Abemaciclib Produces Clinical Benefit in Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 44
- Publication type:
- Article
8
Fam-Trastuzumab Deruxtecan-nxki Improves Efficacy in Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 44
- Publication type:
- Article
9
3 Things You Should Know About Adverse Events With Targeted Therapies for DLBCL.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 40
- Publication type:
- Article
10
The Potential for Improved Processes, Outcomes, and Economics of Health Care.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 38, doi. 10.46883/2025.25921034
- By:
- Publication type:
- Article
11
3 Things You Should Know About Identifying and Treating Epithelioid Sarcoma.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 34
- Publication type:
- Article
12
Insights, Knowledge Gaps, and Priorities in Marginal Zone Lymphoma Research: Report of the Lymphoma Research Foundation's Marginal Zone Lymphoma Workshop.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 10
- By:
- Publication type:
- Article
13
MZL Expert Insights: Summit Sponsored by the Lymphoma Research Foundation.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 1, p. 6
- By:
- Publication type:
- Article